HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

BOL-303225-A

a coumarin-based anti-inflammatory drug; structure in first source

Networked: 1 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Pyrans: 130
    - Benzopyrans: 195
      - Coumarins: 826
        BOL-303225-A: 1
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Benzopyrans: 195
      - Coumarins: 826
        BOL-303225-A: 1

Experts

1.	Baiula, Monica: 1 article (11/2008)
2.	Bucolo, Claudio: 1 article (11/2008)
3.	Maltese, Adriana: 1 article (11/2008)
4.	Maugeri, Francesco: 1 article (11/2008)
5.	Spampinato, Santi: 1 article (11/2008)
6.	Spartà, Antonino: 1 article (11/2008)
7.	Ward, Keith W: 1 article (11/2008)

Related Diseases

1.	Diabetic Retinopathy (Retinopathy, Diabetic) 11/01/2008 - "This study demonstrated that BOL-303225-A acts as an antagonist of the integrin alphaLbeta2 and alphaMbeta2 receptors, suggesting that this drug could be used for ocular diseases such as diabetic retinopathy."
2.	Reperfusion Injury 11/01/2008 - "BOL-303225-A bioavailability in rat plasma and the retinal levels of myeloperoxidase (MPO) after ischaemia-reperfusion injury were evaluated after oral administration (10 mg kg(-1)). "

Related Drugs and Biologics

1.	Lymphocyte Function-Associated Antigen-1 (LFA-1)
2.	Retinaldehyde (Retinal)
3.	Peroxidase (Myeloperoxidase)

Related Therapies and Procedures

1.	Oral Administration